Coya Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.96

-0.30 (-5.70%)

As of May 16, 9:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +642.9% upside

Low Target $27.29

Average Target $36.85

High Target $45.13

Current Price $4.96

Current
$4.96

Target
$36.85

$27.29 $36.85 avg $45.13

Scenario Analysis

Bear Case

$27.29

450.2%

Low target

Base Case

$36.85

+642.9%

Avg target

Bull Case

$45.13

+809.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$7.75

-36.0% from high

52-Week Low

$3.71

+33.7% from low

Target vs 52W High

$36.85

+375.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%